Full Breakdown
Boots Sale Nears Completion with Weston Family
By Drooid · · How we work
Core Event
Sycamore Partners, the private-equity owner of Boots, is reported to be in advanced talks to sell the UK health-and-beauty retailer to the Canadian arm of the billionaire Weston family for roughly $9 billion (including debt). The Wall Street Journal, citing people familiar with the matter, said the transaction could be finalized in the coming weeks. If completed, the deal would transfer ownership of Boots’ 1,800-store UK network and its international operations to the Westons, who are known for Canada’s Loblaws grocery chain and Shoppers Drug Mart pharmacy chain.
Background & Context
Sycamore Partners acquired Walgreens Boots Alliance in a private transaction in 2025, valuing the combined company at about $24 billion (including debt). After the takeover, Sycamore split the business into five stand-alone units to enable the sale of non-core assets, with Boots earmarked for disposal. Earlier this year, Sycamore attempted to sell Boots to Australia’s Sigma Healthcare in a deal that would have valued the retailer at $10 billion, but that bid collapsed. The Weston family previously owned the UK department-store chain Selfridges until its 2022 sale for £4 billion.
Timeline
- 2025 – Sycamore Partners acquires Walgreens Boots Alliance.
- 2025-2026 – Sycamore separates the group into five units, including Boots Group.
- Summer 2026 – Failed sale attempt to Sigma Healthcare at $10 billion.
- September 30, 2026 – Reports emerge that Sycamore is close to a $9 billion sale of Boots to the Canadian Westons.
Data & Statistics
- Store footprint: Boots operates more than 1,800 stores across the United Kingdom.
- Financial performance: In the 12-month period ending August 2025, Boots reported revenue of £7.5 billion (? $9.9 billion) and pretax profit of £337 million, a 25 % increase year-on-year (company accounts filed at Companies House).
- Sales growth: Like-for-like store sales rose 5.8 % in the year to the end of August 2025; Boots.com revenue grew 18.3 % over the same period.
Official Statements & Responses
Both Sycamore Partners and Boots declined to comment on the reported negotiations. A representative for the Weston family was not immediately reachable for comment. The Wall Street Journal noted that the discussions remain confidential and could still fall apart. No official statement was issued regarding the potential impact on a previously speculated initial public offering for Boots.
Why It Matters
The transaction would end speculation about a Boots IPO, removing a rare large-scale listing from the London Stock Exchange, which has seen few new share sales in recent years. Ownership by the Westons could re-align Boots with a family that already has extensive retail experience in the UK and Ireland through Associated British Foods’ Primark stake and historic control of Selfridges. For Sycamore, the sale would represent a $9 billion return on its 2025 acquisition of the broader Walgreens Boots Alliance, testing the firm’s strategy of breaking up and divesting non-core assets.
What's Next
If the deal closes, the Westons will integrate Boots into their existing retail portfolio. The transaction’s completion could trigger further restructuring of the remaining Walgreens Boots Alliance units, which are now privately held and focused on U.S. community pharmacy operations. No specific future dates for regulatory approval or closing have been disclosed.